News

Mr Davis was the chief executive officer for Neurogen Corporation, which was recently acquired by Ligand Pharmaceuticals. His appointment brings the number of AP Pharma board members to

Designed for both demanding research applications and routine laboratory analysis, the Lumina delivers 0.5nm spectral bandwidth, high sensitivity and fast scanning speed, providing performance for assay development, quantification

The combination of both companies capabilities creates a comprehensive biological service offering, encompassing cell line development, analytical and process development and GMP production of recombinant proteins, DNA, viruses

Boehringer said that the FDA approval was supported by clinical pharmacokinetic data, and by a single randomised, double-blind, placebo-controlled multicenter clinical trial. A second study evaluated an overnight

Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications. BioSante reported

Polyphor claimed that the most advanced drug candidate in this new class is POL7080 that selectively kills the dangerous bacteria Pseudomonas aeruginosa. Polyphor has applied its proprietary Protein

The company said that the approval comes after extensive testing and auditing of the Amcor facilities, which have already begun to package the Catrix Wound Dressing. All regulatory

Additionally, the board has also appointed John Lomoro, the company’s chief financial officer, as acting CEO. Reportedly, following the resignation of Juliet Singh from her post as president

The controllers feature universal temperature sensor inputs to minimize stocking and design, a display that can exhibit change of status or alarm, having no need for an HMI,